Department of Ophthalmology and Visual Sciences, University of Wisconsin School of Medicine and Public Health, Madison, WI 53705, USA.
Medicina (Kaunas). 2021 Sep 13;57(9):963. doi: 10.3390/medicina57090963.
: To document, through multimodal imaging, the post-procedural clinical course and visual outcome of a patient who received intra-arterial tissue plasminogen activator (tPA) for acute iatrogenic branch retinal artery occlusion (BRAO), and to review the literature and guidelines regarding the use of tPA for retinal arterial occlusions. : A 28-year-old female patient who sustained an iatrogenic BRAO and subsequently received intra-arterial tPA was followed through her post-interventional course of 3 months with serial exams and multimodal imaging, including color fundus photography, visual field testing, spectral domain optical coherence tomography (SD-OCT), and OCT angiography (OCT-A). : A patient with history of left internal cerebral artery (ICA) aneurysm and baseline visual acuity (VA) of 20/20 developed an acutely symptomatic BRAO after undergoing a neuroendovascular procedure and was acutely treated with tPA through the left ophthalmic artery. At two weeks follow-up, a central posterior pole hemorrhage was noted although VA was preserved. A superior altitudinal defect was shown on automated perimetry. VA dropped to 20/50 at 7 weeks follow-up and hyperreflective material deep to the attachment between the posterior hyaloid and the internal limiting membrane (ILM) consistent with hemorrhage was noted on SD-OCT. At 11 weeks follow-up, VA returned to 20/20, SD-OCT revealed a membrane bridging the foveal depression, OCT-A showed decreased vascularity in the inferior macula, and the visual field defect was stable by automated perimetry. : Intraocular hemorrhage is a possible complication of intra-arterial tPA administration for BRAO, and a careful analysis of risks, benefits, and goals of this procedure must be considered by both provider and patient before such intervention.
: 通过多模态成像,记录接受动脉内组织型纤溶酶原激活物(tPA)治疗急性医源性分支视网膜动脉阻塞(BRAO)患者的术后临床过程和视力结果,并回顾关于 tPA 治疗视网膜动脉阻塞的文献和指南。 : 一名 28 岁女性患者发生医源性 BRAO,随后接受动脉内 tPA 治疗,通过连续检查和多模态成像(包括眼底彩色照相、视野测试、谱域光学相干断层扫描(SD-OCT)和 OCT 血管造影(OCT-A))对其进行了 3 个月的随访。 : 一名有左侧颈内动脉(ICA)动脉瘤病史和基线视力(VA)为 20/20 的患者,在行神经血管介入手术后发生急性症状性 BRAO,并通过左侧眼动脉接受 tPA 急性治疗。在两周随访时,尽管 VA 保持不变,但注意到后极中央后极出血。自动视野计显示上方垂直缺损。在 7 周随访时,VA 降至 20/50,SD-OCT 显示后玻璃体内膜与内界膜(ILM)之间附着处深方有高反射物质,符合出血。在 11 周随访时,VA 恢复到 20/20,SD-OCT 显示膜桥接了黄斑凹,OCT-A 显示下黄斑血管密度降低,自动视野计显示视野缺损稳定。 : 眼内出血是 BRAO 动脉内 tPA 治疗的一种可能并发症,在进行这种干预之前,提供者和患者必须仔细分析这种手术的风险、益处和目标。